Literature DB >> 21418296

18F-FDG-PET/CT in the assessment of pancreatic cancer: is the contrast or a better-designed trial needed?

Nam Q Nguyen, Dylan F Bartholomeusz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21418296     DOI： 10.1111/j.1440-1746.2011.06625.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN： 0815-9319            Impact factor:   4.029


× No keyword cloud information.
  2 in total

1.  Dual Targeting of Tissue Factor and CD105 for Preclinical PET Imaging of Pancreatic Cancer.

Authors:  Haiming Luo; Christopher G England; Sixiang Shi; Stephen A Graves; Reinier Hernandez; Bai Liu; Charles P Theuer; Hing C Wong; Robert J Nickles; Weibo Cai
Journal:  Clin Cancer Res       Date:  2016-03-29       Impact factor: 12.531

2.  Consistent surgeon evaluations of three-dimensional rendering of PET/CT scans of the abdomen of a patient with a ductal pancreatic mass.

Authors:  Matthew E Wampole; John C Kairys; Edith P Mitchell; Martha L Ankeny; Mathew L Thakur; Eric Wickstrom
Journal:  PLoS One       Date:  2013-09-24       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.